Eastman Kodak seems to have mucked up nearly everything surrounding a $765 million government loan that would have enabled it to get into the pharmaceuticals business. The deal has been put on hold, and the U.S. Securities and Exchange Commission (SEC) is reportedly investigating the matter. The beleaguered former photography giant was hit another blow
